Santat L, Paz H, Wong CA, Li LJ, Macer JA, Forman SJ, Wong KK, Chatterjee S. Recombinant AAV2 transduction of primitive human hematopoietic stem cells capable of serial engraftment in immune-deficient mice. Proc Nat Acad Sci 2005;102:11053-11058.
Sun JY, Senitzer D, Forman SJ, Chatterjee S, Wong KK. Identification of new MHC restriction elements for presentation of the p210 BCR-ABL fusion region to human cytotoxic T lymphocytes (CTL), Cancer Immunol Immunother. 2003; 52: 761-70. 35.
Sun JY, Jawa-Anand V, Chatterjee S, Wong K.K. Jr. Immune Responses to Adeno-Associated Virus (AAV) and Its Recombinant Vectors. Gene Therapy. Gene Ther. 2003; 10: 964-76.
Sun JY, Chatterjee S and Wong KK Jr. Immunogenic issues concerning recombinant adeno-associated virus vectors for gene therapy. Current Gene Therapy. 2002; 2:485-500.
Sun J-Y, Krouse RS, Chatterjee S, Forman SJ, Sniecinski I, Senitzer D, Wong KK. Immunogenicity of a P210 BCR-ABL Fusion Domain Candidate DNA Vaccine Targeted to Dendritic Cells by an rAAV Vector In Vitro. Cancer Res. 2002;62:3175-83.
Wong KK, and Chatterjee S. Parvovirus Vectors for Gene Therapy of Cancer, in Cancer Gene Therapy, E. Lattime and S. Gerson, Eds. Academic Press, 2002.
Chatterjee S, Wong KK. Adeno-associated virus vectors for the delivery of ribozymes. In “Intracellular Ribozyme Applications: Principles and Protocols.” JJ Rossi and L Couture (Eds). Pp 189-215, Horizon Scientific Press, 1999.
Mi J, Chatterjee S, Wong KK, Forbes C, Lawless G, Tobin AJ. Recombinant adeno-associated virus (AAV) drives constitutive production of glutamate decarboxylase in neural cell lines. J Neurosci Res, 57:137-149, 1999.
Chatterjee S, Li W, Wong C, Lu D, Fisher-Adams G, Guha M, Macer J, Forman SJ, Wong KK. Transduction of primitive human marrow and cord blood-derived hematopoietic progenitor cells with adeno-associated virus vectors. Blood 93:1882-1894, 1999.
Fisher-Adams G, Wong KK Jr, Forman S, Podsakoff GM, Chatterjee S. Integration of adeno-associated virus vector genomes in Human CD34 cells following transduction. Blood 1996;88:492-504.
Chatterjee S, Wong KK Jr. Adeno-associated virus vectors for gene therapy of the hematopoietic system. Curr Top Microbiol Immunol, 1996;218:61-73.
Chatterjee S, Lu D, Podsakoff GM, Wong, KK. Strategies for efficient Gene transfer into hematopoietic cells: The use of adeno-associated virus vectors in gene therapy. Ann New York Acad Sci. 1995;770:79-90.
Lu D, Chatterjee S, Brar D, Wong KK, Jr. High efficiency in vitro cleavage of transcripts arising from the major transforming genes of human papillomavirus type 16 mediated by ribozymes transcribed from an adeno-associated virus-based vector. Cancer Gene Therapy, 1994;1:267-277.
Podsakoff G, Wong KK Jr, Chatterjee S. Stable and efficient gene transfer into non-dividing cells by adeno-associated virus (AAV)-based vectors. J Virol 1994;68:5656-5666.
Chatterjee S, Wong KK, Jr, Lu D, Permana P, Podsakoff G. Novel approaches for efficient gene transfer into hematopoietic progenitor cells: the use of adeno-associated virus vectors. Bone Marrow Transplantation 1995;15:S309-S313.
Chatterjee S, Wong KK, Jr. Adeno-associated viral vectors for the delivery of antisense RNA.Methods: a companion to Methods in Enzymology; 1993;5:51-59.
Zaia JA, Chatterjee S, Wong KK, Elkins D, Taylor NR, Rossi JJ. Status of ribozyme and antisense-based developmental approaches for anti-HIV-1 therapy. Ann New York Acad Sci, Vol 660, 95-105,1992.
Chatterjee S, Johnson PR, Wong KK, Jr. Dual target inhibition of HIV-1 in vitro by means of an adeno-associated virus antisense vector. Science 1992;258:1485-1488.
This is a partial list. Full publications list available upon request. Information on this page may be self-reported and subject to change at any time. Last reviewed: 07/08.